arcadia

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE601.65-1.9 (-0.31 %)
PREV CLOSE ( ) 603.55
OPEN PRICE ( ) 609.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 307237
TODAY'S LOW / HIGH ( )600.50 609.80
52 WK LOW / HIGH ( )508.1 663
NSE603.500.65 (+0.11 %)
PREV CLOSE( ) 602.85
OPEN PRICE ( ) 608.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 603.50 (500)
VOLUME 3052143
TODAY'S LOW / HIGH( ) 602.00 609.70
52 WK LOW / HIGH ( )507.2 663.4
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 022-24826951

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
21Jun Cipla, GAIL and Capital First to see s
Cipla has received final approval for its Abbreviated New Drug Applicati..
21Jun Cipla gets approval for Testosterone C
Cipla has received final approval for its Abbreviated New Drug Applicati..
21Jun Cipla moves up on getting approval for
Cipla is currently trading at Rs. 604.75, up by 1.20 points or 0.20% fro..
20Jun Cipla receives approval for Efavirenz
Cipla has received final approval for its Abbreviated New Drug Applicati..
20Jun Kansai Nerolac, Sadbhav Infra and Tata
Kansai Nerolac Paints is in process to acquire 55% equity stake in Bangl..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit2248.114685.2
Gross Profit 2716.7 19114
Operating Profit 4862.325304.3
Net Sales 27253.4114448.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7297.95 (1.99%)
M.Cap ( in Cr)15507.63
Jenburkt Pharma (BSE)
 730.50 (2.74%)
M.Cap ( in Cr)335.25
Zim Laboratories (BSE)
 309.20 (4.99%)
M.Cap ( in Cr)249.21
Glenmark Pharma (BSE)
 601.75 (1.93%)
M.Cap ( in Cr)16979.47
NGL Fine-Chem (BSE)
 357.30 (1.65%)
M.Cap ( in Cr)220.74
Shareholding Pattern
PROMOTERS 37.21%
NON-INSTITUTION 24.69%
MUTUAL FUNDS/UTI 10.07%
FI/BANKS/INSURANCE 3.81%
FII 0.31%
GOVERNMENT 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM